Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients

被引：1
|
作者：
Benenati, Stefano [1 ]
Porto, Italo [1 ,2 ]
机构：
[1] Univ Genoa, Cardiovasc Dis Chair, Dept Internal Med DiMI, Largo Rosanna Benzi 10, I-16132 Genoa, GE, Italy
[2] IRCCS Osped Policlin San Martino, IRCCS Italian Cardiol Network, Cardiovasc Dis Unit, Genoa, Italy
来源：
JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 2022年 / 54卷 / 01期
关键词：
Dual antiplatelet therapy; Drug-eluting stent; Biodegradable polymer; Durable polymer; Percutaneous coronary intervention;
D O I：
10.1007/s11239-022-02639-z
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：153 / 155
页数：3
相关论文
共 50 条
  • [31] Duration of dual antiplatelet therapy following drug-eluting coronary stents: Longer or shorter?
    Fan, Zhixing
    Yang, Jian
    Yang, Chaojun
    Yang, Jun
    Zeng, Ping
    Guo, Xin
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 202 : 936 - 937
  • [32] Contemporary use of drug-eluting stents
    Chu W.W.
    Waksman R.
    [J]. Current Treatment Options in Cardiovascular Medicine, 2005, 7 (1) : 35 - 46
  • [33] Compliance With Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Drug-Eluting Stents
    de Sa, Daniel D. Correa
    Lennon, Ryan J.
    Bresnahan, John F.
    Rihal, Charanjit S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A371 - A371
  • [34] Dual antiplatelet therapy, drug-eluting stents and bioresorbable vascular scaffolds: Evolutionary perspectives
    Albuquerque, Felipe N.
    Bortnick, Anna
    Iqbal, Javaid
    Ishibashi, Yuki
    Stone, Gregg W.
    Serruys, Patrick W.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (05) : 909 - 919
  • [35] Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy
    Kereiakes, Dean J.
    Yeh, Robert W.
    Massaro, Joseph M.
    Driscoll-Shempp, Priscilla
    Cutlip, Donald E.
    Steg, P. Gabriel
    Gershlick, Anthony H.
    Darius, Harald
    Meredith, Ian T.
    Ormiston, John
    Tanguay, Jean-Francois
    Windecker, Stephan
    Garratt, Kirk N.
    Kandzari, David E.
    Lee, David P.
    Simon, Daniel I.
    Iancu, Adrian Corneliu
    Trebacz, Jaroslaw
    Mauri, Laura
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1552 - 1562
  • [36] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, Olusegun
    Perez, Xavier
    Bredy-Pierre-Louis
    Kurian, Damian
    [J]. CARDIOLOGY JOURNAL, 2016, 23 (03) : 307 - 316
  • [37] The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents
    Sheyin, O.
    Perez, X.
    Pierre-Louis, B.
    Kurian, D.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 512 - 512
  • [38] Dual antiplatelet therapy and drug eluting stents: A marriage of convenience
    Benezet-Mazuecos J.
    Ibanez B.
    Badimon J.J.
    [J]. Thrombosis Journal, 5 (1)
  • [39] Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
    Sambola, Antonia
    Garcia-Dorado, David
    [J]. CORONARY ARTERY DISEASE, 2015, 26 (05) : 367 - 368
  • [40] Safety of Dual Antiplatelet Therapy in Patients Treated with Coronary Drug Eluting Stents
    Drewnicki, Andrzej
    Lesiak, Maciej
    Pyda, Malgorzata
    Grygier, Marek
    Skorupski, Wlodzimierz
    Araszkiewicz, Aleksander
    Mitkowski, Przemyslaw
    Grajek, Stefan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B41 - B41
12345